Cisplatin-induced ototoxicity is correlated with functional and morphological changes in the organ of Corti, the stria vascularis and the spiral ganglion. However, the cochlear sites of cisplatin uptake and accumulation have not been properly identified. Therefore, we have developed an immunohistochemical method to, indirectly, detect cisplatin in semithin cryosections of the guinea pig cochlea (basal turn) using an antiserum containing antibodies against cisplatin-DNA adducts. Platinated DNA was present in the nuclei of most cells in the organ of Corti and the lateral wall after cisplatin administration. Nuclear immunostaining was most pronounced in the outer hair cells, the marginal cells and the spiral ligament fibrocytes. This study is the first to demonstrate the presence of cisplatin in histological sections of the cochlea.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.heares.2004.12.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS storm.
Biomaterials
March 2025
Department of Nanomedicine, Houston Methodist Academic Institute, Houston, TX, 77030, USA. Electronic address:
Article Synopsis
- Induction of reactive oxygen species (ROS) is crucial for cancer treatment, but current methods are often ineffective due to low ROS production.
- Researchers have developed a new platinum-based drug called "carrier-platin," which uses nanoparticles to significantly boost ROS production in cancer cells, leading to rapid cell death (within 30 minutes).
- Unlike traditional platinum drugs that target DNA, carrier-platin kills cancer cells through a unique mechanism that bypasses DNA damage, showing enhanced effectiveness against a wide range of cancers, including those resistant to other treatments, with minimal side effects.
Reactions of Cisplatin with Thioredoxin-1 Regulate Intracellular Redox Homeostasis.
Inorg Chem
June 2024
Key Laboratory of Precision and Intelligent Chemistry, School of Chemistry and Materials Science, University of Science and Technology of China, Hefei, Anhui 230026, China.
Cisplatin is a widely used anticancer drug. In addition to inducing DNA damage, increased levels of reactive oxygen species (ROS) play a significant role in cisplatin-induced cell death. Thioredoxin-1 (Trx1), a redox regulatory protein that can scavenge ROS, has been found to eliminate cisplatin-induced ROS, while elevated Trx1 levels are associated with cisplatin resistance.
View Article and Find Full Text PDFSynthesis of substituted terpyridine nickel nitrate complexes and their inhibitory selectivity against cancer cell lines.
J Inorg Biochem
July 2024
School of Chemistry and Chemical Engineering, Guangxi University, 530004 Nanning, Guangxi, China. Electronic address:
Six terpyridine‑nickel complexes 1-6 were formed by the coordination of 4'-(4-R-phenyl)-2,2':6',2″-terpyridine (R = hydroxyl (L), methoxyl (L), methylsulfonyl (L), fluoro (L), bromo (L), iodo (L)) derivatives to nickel nitrate. The compositions and structures of these complexes were analyzed by Fourier Transform infrared spectroscopy (FT-IR), elemental analyses, electrospray ionization mass spectra (ESI-MS), solid-state ultraviolet-visible (UV-Vis) spectroscopy, and single crystal X-ray diffraction (1, 2 and 4) studies. In vitro anticancer cell proliferation experiments against SiHa (human cervical squamous cancer cell line) cells, Bel-7402 (human hepatoma cancer cell line), Eca-109 (human esophageal cancer cell line) and HL-7702 (human normal hepatocyte cell line) indicate that they have more excellent anti-proliferation effects than the cis-platin against Siha cells, Bel-7402 cells and Eca-109 cells.
View Article and Find Full Text PDFRNA is a pro-apoptotic target of cisplatin in cancer cell lines and C. elegans.
Biomed Pharmacother
April 2024
University of Heidelberg, Medical Faculty of Heidelberg, Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, Heidelberg 69120, Germany. Electronic address:
Cisplatin not only targets DNA but also RNA. However, it is largely unknown whether platinated RNA (Pt-RNA) causes apoptosis and thus contributes to the cytotoxic effects of cisplatin. Consequently, cellular RNA was isolated from HepG2 and LS180 cells, exposed to cisplatin, and the resulting Pt-RNA (20 ng Pt/µg RNA) was transfected into these cancer cell lines or used to treat an apoptosis reporter Caenorhabditis elegans (C.
View Article and Find Full Text PDFCell death in cancer chemotherapy using taxanes.
Front Pharmacol
January 2024
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, United States.
Article Synopsis
- Cancer cells develop resistance to natural cell death mechanisms, making them harder to eliminate, which is a challenge for chemotherapy aiming to specifically target these malignant cells.
- Chemotherapy often combines platinum agents (like cisplatin) that damage DNA and taxanes (like paclitaxel) that stabilize microtubules, leading to effective cancer cell elimination through mechanisms such as mitotic arrest and potential induction of cell death.
- Recent research suggests that taxanes may also cause a unique form of cell death through micronucleation and rupture of the nuclear membrane, rather than traditional apoptosis, contributing to their effectiveness in cancer treatment.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!